Clinical trials
Completed trials in Bolivia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centro Pediatrico Albina de Patino | 6 |
| AB Foundation | 3 |
| Centre Paul Strauss | 3 |
| Fundacion Nacional de Dermatologia | 3 |
| University of Michigan | 3 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2 |
| Drugs for Neglected Diseases | 2 |
| Knight Therapeutics (USA) Inc | 2 |
| University of Heidelberg Medical Center | 2 |
| ASST Gaetano Pini-CTO | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leishmaniasis | 8 |
| Chagas Disease | 5 |
| Leishmaniasis, Cutaneous | 5 |
| Leishmaniasis, Mucocutaneous | 4 |
| Acute Kidney Injury | 3 |
| Diarrhea | 3 |
| Gallbladder Neoplasms | 3 |
| Chronic Disease | 2 |
| Diabetes Mellitus | 2 |
| Hypertension | 2 |
Trials
Showing 76 to 54 of 54. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.